| Biomarker ID | 1809 |
| PMID | 30337219 |
| Year | 2018 |
| Biomarker | AMACR (Alpha methylacyl A coenzyme racemase) |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Semen |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Lipid and lipoprotein metabolism, T cell receptor regulation of apoptosis, Metabolism, Peroxisome, Beta-oxidation of pristanoyl-CoA |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 28 biopsy proven CaP patients prior to radical prostatectomy and 15 age-comparable controls were selected for the analysis |
| Senstivity | 85.7% |
| Specificity | 53.3% |
| AUC | 0.7 (95% CI: 0.65-0.87) |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |